| Isolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analogues L Fakhouri, T El-Elimat, DP Hurst, PH Reggio, CJ Pearce, NH Oberlies, ... Bioorganic & medicinal chemistry 23 (21), 6993-6999, 2015 | 31 | 2015 |
| Design, synthesis and biological evaluation of GPR55 agonists L Fakhouri, CD Cook, MH Al-Huniti, LM Console-Bram, DP Hurst, ... Bioorganic & medicinal chemistry 25 (16), 4355-4367, 2017 | 13 | 2017 |
| Discovery of a nanomolar glyoxalase-I inhibitor using integrated ligand-based pharmacophore modeling and molecular docking NA Al-Shar’i, EK Al-Rousan, LI Fakhouri, QA Al-Balas, MA Hassan Medicinal Chemistry Research 29, 356-376, 2020 | 11 | 2020 |
| The design of TOPK inhibitors using structure-based pharmacophore modeling and molecular docking based on an MD-refined homology model LI Fakhouri, NA Al-Shar’i Molecular Diversity, 1-24, 2022 | 1 | 2022 |
| Design, Synthesis and Biological Evaluation of Potent Thiazolidinedione Salicylic Acid Inhibitors Against Glyoxalase-I as Potential Anticancer Agents BO Alomari, L Fakhouri, NA Al-Shar’i, Q Albalas | | 2024 |
| Non-aromatic difluoro analogues of resorcylic acid lactones MP Croatt, L Fakhouri, NH Oberlies, C Pearce US Patent 10,632,099, 2020 | | 2020 |
| Non-aromatic difluoro analogues of resorcylic acid lactones MP Croatt, L Fakhouri, NH Oberlies, C Pearce US Patent 10,434,085, 2019 | | 2019 |
| Optimization of Synthetically Novel Agonists of the Putative Cannabinoid Receptor, GPR55, using an Activated State Model MA Lingerfelt, P Zhao, L Fakhouri, ME Abood, MP Croatt, PH Reggio Biophysical Journal 108 (2), 415a, 2015 | | 2015 |
| Synthesis and biological evaluation of GPR55 agonists L Fakhouri, H Sharir, D Hurst, M Abood, P Reggio, M Croatt ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 245, 2013 | | 2013 |
